Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  New Zealand Stock Exchange  >  AFT Pharmaceuticals Limited    AFT   NZAFTE0001S4

AFT PHARMACEUTICALS LIMITED

(AFT)
  Report
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote New Zealand Stock Exchang…
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
4.89 4.75 4.7 4.8 4.76 Last
393969 269244 89199 205090 34856 Volume
-1.21% -2.86% -1.05% +2.13% -0.83% Change
Financials
Sales 2021 118 M 82,7 M 82,7 M
Net income 2021 11,7 M 8,18 M 8,18 M
Net Debt 2021 26,2 M 18,4 M 18,4 M
P/E ratio 2021 42,5x
Yield 2021 -
Sales 2022 140 M 98,6 M 98,6 M
Net income 2022 20,8 M 14,6 M 14,6 M
Net Debt 2022 18,5 M 13,0 M 13,0 M
P/E ratio 2022 23,9x
Yield 2022 0,90%
Capitalization 498 M 350 M 350 M
EV / Sales 2021 4,45x
EV / Sales 2022 3,68x
Nbr of Employees 86
Free-Float 28,2%
More Financials
Company
AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The Company's NasoSURF Nebuliser is in pilot scale production. The Company is focused on conducting clinical... 
Sector
Pharmaceuticals
Calendar
05/26Earnings Release
More about the company
All news about AFT PHARMACEUTICALS LIMITED
11/19AFT PHARMACEUTICALS : Financial results for half year ended 30 september 2020
AQ
11/18AFT PHARMACEUTICALS : FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2020Ope..
PU
11/18AFT PHARMACEUTICALS : Opening european office, signs new partners for maxigesic ..
AQ
11/17AFT PHARMACEUTICALS : AFP opening European office, signs new partners for MXGOpe..
PU
11/09AFT PHARMACEUTICALS : Welcomes us fda complete response letter
AQ
11/08AFT PHARMACEUTICALS : welcomes US FDA Complete Response LetterOpens in a new Win..
PU
11/03AFT PHARMACEUTICALS : AFP appoints Anita Baldauf as a directorOpens in a new Win..
PU
11/03AFT PHARMACEUTICALS : Maxigesic iv distribution deals signed in uk and hong kong
AQ
10/21RLG : Kiwi Health Flagship Store Launch in China-Tmall GlobalOpens in a new Wind..
PU
10/15AFT PHARMACEUTICALS : To announce half year interim results on thursday november..
AQ
09/08AFT PHARMACEUTICALS : ASM resultsOpens in a new Window
PU
09/08MEETING : AFT: ASM ResultsOpens in a new Window
PU
09/07AFT PHARMACEUTICALS : ASM PresentationOpens in a new Window
PU
08/24AFT PHARMACEUTICALS : Notice of adjourned annual meeting of shareholders 2020
AQ
08/23AFT PHARMACEUTICALS : AGM Virtual Meeting GuideOpens in a new Window
PU
More news
News in other languages on AFT PHARMACEUTICALS LIMITED

- No features available -

More news
Chart AFT PHARMACEUTICALS LIMITED
Duration : Period :
AFT Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AFT PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 5,75 NZD
Last Close Price 4,76 NZD
Spread / Highest target 36,6%
Spread / Average Target 20,8%
Spread / Lowest Target 5,04%
EPS Revisions
Managers
NameTitle
Hartley Atkinson Chief Executive Officer, Executive Director & MD
David Mark Flacks Chairman
Malcolm Tubby Chief Financial Officer & Secretary
Douglas John Wilson Independent Non-Executive Director
Marree Atkinson Executive Director & Chief of Staff
Sector and Competitors